Cargando…
Targeting BPTF Sensitizes Pancreatic Ductal Adenocarcinoma to Chemotherapy by Repressing ABC-Transporters and Impairing Multidrug Resistance (MDR)
SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma is a devastating disease and an extremely chemoresistant tumour. In the present manuscript, we described the role of BPTF during tumour pancreatic ductal adenocarcinoma progression and in response to gemcitabine treatment, a gold standard treatment in...
Autores principales: | Muñoz Velasco, Raúl, Jiménez Sánchez, Paula, García García, Ana, Blanco Martinez-Illescas, Raquel, Pastor Senovilla, Ángela, Lozano Yagüe, Marian, Trento, Alfonsina, García-Martin, Rosa María, Navarro, Diego, Sainz, Bruno, Rodríguez Peralto, José Luis, Sánchez-Arévalo Lobo, Víctor Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946837/ https://www.ncbi.nlm.nih.gov/pubmed/35326669 http://dx.doi.org/10.3390/cancers14061518 |
Ejemplares similares
-
BPTF is required for c-MYC transcriptional activity and in vivo tumorigenesis
por: Richart, Laia, et al.
Publicado: (2016) -
Evaluation the interaction of ABC multidrug transporter MDR1 with thymoquinone: substrate or inhibitor?
por: Keyvani, Vahideh, et al.
Publicado: (2020) -
The Role of BPTF in Melanoma Progression and in Response to BRAF-Targeted Therapy
por: Dar, Altaf A., et al.
Publicado: (2015) -
pTERT C250T mutation: A potential biomarker of poor prognosis in metastatic melanoma
por: Blanco-García, Leyla, et al.
Publicado: (2023) -
BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas
por: Dai, Meng, et al.
Publicado: (2015)